1Dennis LK.Analysis of the melanoma epidemic,both apparent and real:data from the 1973 through 1994 surveillance,epidemiology,and end results program registry[J].Arch Dermatol,1999,135(3):275-280.
2Pu LL,Cruse CW,Wells KE,et al.Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity[J].Plast Reconstr Surg,1999,104 (4):964-969.
3Sersa G,Stabuc B,Cemazar M,et al.Electrochemotherapy with cisplatin:experience in malignant melanoma patients[J].Clin Cancer Res,2000,6(3):863-867.
4Enk AH,Nashan D,Rubben A,et al.High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma[J].Cancer,2000,88(9):2042-2046.
5Ascierto PA,Palmieri G,Parasole R,et al.3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma[J].Int J Mol Med,1999,3 (3):303-306.
6Grimm EA,Smid CM,Lee JJ,et al.Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy[J].Clin Cancer Res,2000,6 (10):3895-3903.
7McClay EF,McClay ME,Monroe L,et al.The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma[J].J Cancer,2000,83(1):16-21.
8Yamazaki N,Yamamoto A,Wads T,et al.Dacarbazine,nimustine hydrochloride,cisplatin and tamoxifen combination chemotherapy for advanced malignant melanoma[J].J Dermatol,1999,26(8):489-493.
9Graham MV.Hypofractionated radiation therapy in the modern era[J].Rays,1999,24 (3):400-405.
10Fenig E,Eidelevich E,Njuguna E,et al.Role of radiation therapy in the management of cutaneous malignant melanoma[J].Am J Clin Oncol,1999,22 (2):184-186.
